VP Clinical Operations
- Passionate about developing novel treatment protocols in CNStherapeutics to advance unmet medical needs. Translate business strategy into optimal solutions by building and partnering with premier providers
- Well networked in developing and nurturing strong Key Opinion Leader (KOL)relationships in Phase I - IV Trials.
- Extensive background in various therapeutic areas (TAs) with a special emphasis on CNS indications. Experience includes, Alzheimer’s, mild cognitive impairment, schizophrenia (CIAS, negative, and positive symptoms), bipolar disorder (mania and depressive state) and MDD.
- Significant experience with the unique challenges in phase I (first in human, SAD, MAD, complex cohort management) and orphan indications (Friederichs’s ataxia, behavioral variant FTD, FTD with Progranulin Mutation).